A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Recruiting · Phase 3 · NCT06739122
Conditions: Type 2 Diabetes
At a glance
- Research payments reported, 2025
- $581,686
- U.S. investigators named
- 26
- Sites paid
- 26
- Planned or actual enrollment
- 55
About the trial
- Sponsor
- Eli Lilly and Company
- Tested
- Dulaglutide (drug)
- Dates
- Started 2025-01-10; completion 2027-12
- Results posted
- Not yet
The main purpose of this study is to evaluate additional dosing options for dulaglutide in pediatric participants with Type 2 Diabetes. Participation in this study will last about 8 months.
From ClinicalTrials.gov, last updated 2026-08-07. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Eli Lilly and Company reported $581,686 in research payments for this study in 2025 (50 payments).
Products named: Trulicity
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Jon D. Oden, MD Pediatric Endocrinology · Little Rock, AR
- Sunil K. Sinha, MBBS Pediatric Endocrinology · Tucson, AZ
- Lily C. Chao, MD Pediatric Endocrinology · Los Angeles, CA
- Shylaja Srinivasan, MD Pediatric Endocrinology · Salinas, CA
- Michelle A. Van Name Pediatric Endocrinology · New Haven, CT
- Doris E. Estrada, MD Pediatric Endocrinology · Washington, DC
- J. Desiree Pineda, MD Endocrinology & Diabetes · Washington, DC
- Helena M. Gaviria, MD Pediatrics · Tamarac, FL
- Yanetsi Landa-colon, MD. Pediatric Emergency Medicine · Fort Lauderdale, FL
- Konda M. Reddy, MD Pediatric Endocrinology · Winter Park, FL
- Jacqueline Chan, M.D. Pediatric Endocrinology · Augusta, GA
- Daniel S. Hsia, M.D. Pediatric Endocrinology · Atlanta, GA
- Steven B. Leichter, M.D. Endocrinology & Diabetes · Columbus, GA
- Daniel P. Flynn, MD Pediatric Endocrinology · Boise, ID
- Roxana L. Aguirre Castaneda Pediatric Endocrinology · Chicago, IL
- Benjamin U. Nwosu, M.D. Pediatric Endocrinology · Worcester, MA
- Naznin M. Dixit, MD DM Pediatric Endocrinology · Jackson, MS
- Camila F. Pereira-eshraghi, MD Pediatric Endocrinology · Clifton, NJ
- Michele R. Hutchison, MD PHD Pediatric Endocrinology · Albuquerque, NM
- Kathleen E. Bethin, MD Pediatric Endocrinology · Buffalo, NY
- David W. Hansen, MD Pediatric Endocrinology · Syracuse, NY
- Amy S. Shah, M.D. Pediatric Endocrinology · Cincinnati, OH
- Steven M. Willi, M.D. Pediatric Endocrinology · Philadelphia, PA
- Alison J. Lunsford, M.D. Pediatric Endocrinology · Columbia, SC
- Siripoom Mckay, MD Endocrinology & Diabetes · Houston, TX
- Petter M. Bjornstad, MD Pediatric Endocrinology · Seattle, WA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Research Foundation of State Univ of Ny $83,036
- Baylor College of Medicine $42,111
- Yale University $39,006
- Childrens Healthcare of Atlanta $38,906
- Prisma Health Richland Hospital, SC $36,293
- D&h National Research Centers $34,402
- Feinstein Institute for Medical $33,810
- Adventhealth Orlando, FL $33,266
- University of California Davis Medical Center, CA $31,403
- Children's Hospital of Philadelphia, PA $26,700
- Univ of Arizona DBA Arizona Board of Regents $26,130
- Nemours Children's Hospital, Delaware, DE $24,217
- Children's Hosp of Los Angeles, CA $23,375
- University of Mississippi Med Center, MS $23,016
- St Luke's Regional Medical Center, ID $18,750
- Cr Services Acquisition US LLC $17,237
- Emerson Clinical Research Inst $16,768
- University of New Mexico $13,760
- D and H Tamarac Research Center $11,250
- Arkansas Childrens Hospital $7,850
- $304
- Seattle Children's Hospital, WA $16
- Columbus Clinical Research Inc $16
- Cincinnati Children's Hospital Medical Center, OH $16
- University of Illinois Hospital and Clinics, IL $16
- University of Utah Hospital and Clinics, UT $16
- Childrens Research Institute $16
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.